Skip to main content
Clinical Trials/TCTR20220714001
TCTR20220714001
Recruiting
N/A

ewborn hearing screening in neonates born to mothers with COVID-19 during pregnancy

/A0 sites183 target enrollmentJuly 14, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Hearing screening of neonates born to women who were positive SARS-CoV-2 PCR during pregnancy
Sponsor
/A
Enrollment
183
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 14, 2022
End Date
August 31, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • 1\. Neonates born to mothers who were positive SARS\-CoV\-2 PCR during pregnancy or neonates born to healthy women
  • 2\. Neonates with normal ear canal
  • 3\. Singleton

Exclusion Criteria

  • 1\. Family of childhood hearing loss
  • 2\. Admitted in neonatal intensive care more than 5 days
  • 3\. Hyperbilirubinemia with exchange transfusion
  • 4\. Aminoglycoside administration for more than 5 days,
  • 5\. Asphyxia or hypoxic ischemic encephalopathy, extracorporeal membrane oxygenation (ECMO)
  • 6\. In utero infections of toxoplasmosis, rubella, cytomegalovirus, herpes, syphilis,Zika
  • 7\. Craniofacial malformation
  • 8\. Syndrome associated with hearing loss
  • 9\. Culture\-positive infection associated with sensorineural hearing loss
  • 10\. Major birth head injury to skull (for example Skull fracture)

Outcomes

Primary Outcomes

Not specified

Similar Trials